HTS and hit finding in academia--from chemical genomics to drug discovery.
about
Fexinidazole--a new oral nitroimidazole drug candidate entering clinical development for the treatment of sleeping sicknessAutomated high-content live animal drug screening using C. elegans expressing the aggregation prone serpin α1-antitrypsin ZA rapid and affordable screening platform for membrane protein trafficking.Assay strategies for the discovery and validation of therapeutics targeting Brugia pahangi Hsp90Open access high throughput drug discovery in the public domain: a Mount Everest in the making.Drug Discovery in Academia- the third way?ACFIS: a web server for fragment-based drug discoveryNovel chiral skeletons for drug discovery: antibacterial tetramic acids.An inexpensive high-throughput nuclear magnetic resonance tube cleaning apparatus.Probing the probes: fitness factors for small molecule tools.Compound prioritization methods increase rates of chemical probe discovery in model organisms.Principles of early drug discovery.Diversity-oriented synthesis: producing chemical tools for dissecting biology.Efficient drug screening and gene correction for treating liver disease using patient-specific stem cells.Mining collections of compounds with Screening Assistant 2A strategy for the diversity-oriented synthesis of macrocyclic scaffolds using multidimensional coupling.Identification of therapeutic small-molecule leads in cultured cells using multiplexed pathway reporter readoutsUS academic drug discovery.Identification of compound-protein interactions through the analysis of gene ontology, KEGG enrichment for proteins and molecular fragments of compounds.Biofocussed chemoprospecting: An efficient approach for drug discovery.Is amyloid binding alcohol dehydrogenase a drug target for treating Alzheimer's disease?Synthesis of heterocycles by formal cycloadditions of isocyanides.The use of high-throughput screening in identifying chemotherapeutic agents for gastric cancer.Modern approaches to accelerate discovery of new antischistosomal drugs.An update on the use of C. elegans for preclinical drug discovery: screening and identifying anti-infective drugs.Dual-bioactivity-based liquid chromatography-coupled quadrupole time-of-flight mass spectrometry for NF-κB inhibitors and β2AR agonists identification in Chinese Medicinal Preparation Qingfei Xiaoyan Wan.Stereodivergent, Diels-Alder-initiated organocascades employing α,β-unsaturated acylammonium salts: scope, mechanism, and application.SwissTargetPrediction: a web server for target prediction of bioactive small molecules.Biomimetic synthesis, antibacterial activity and structure-activity properties of the pyroglutamate core of oxazolomycin.Natural products chemistry: The emerging trends and prospective goals.PubChem BioAssay: A Decade's Development toward Open High-Throughput Screening Data SharingThe pharmaceutical industry and natural products: historical status and new trends
P2860
Q21144517-FFE09AD4-6F80-4608-8C73-514E06102FDDQ21562132-5F58E0D1-36C6-4BDB-9894-7031043966C8Q27305088-7A9AFC51-A323-41F8-BF89-C35969DB1446Q28474428-D1751659-64B2-45FB-BF23-3B59734CF1E5Q28677005-6808E687-8599-4C6E-ABC7-2854D57B4890Q28749049-8981F515-99C5-4975-8171-833967ADEF25Q28830078-0B880C79-AEBB-4494-924E-BB20B6C1B665Q33893201-66814643-ABE9-4B79-A71A-BFE1A228EDF7Q33922518-7C59B729-5917-4F2F-8578-D155B7BB0C11Q34001269-6C5ABD62-A04D-40E2-8F6E-A5AB7EFA7800Q34061093-3C91D9AB-1A52-475A-A4DB-B4FA734250F6Q34150775-3BD833CC-B436-4078-9381-C6DC08217595Q34227440-C0B75A0A-0FF9-456F-B307-EF5715849470Q34550486-4168DF20-3F18-4F5C-A2C5-94482148E48DQ34552776-0156794C-1AE7-4184-878F-8A398864DA64Q34993742-8673800B-9371-45AA-942A-7D4DBCB03041Q35548686-4E5774CB-15A9-418D-977B-A1CE8FA15354Q35702741-4F9E03F0-24F6-49AE-919A-D5C04D13E3F4Q36105215-1BBA9C91-843F-4320-ACF2-55C011213B55Q36264598-5A397552-F251-4855-9780-0C40201B6F64Q36908481-39B756DE-F7AA-430B-9255-90825FAD683AQ38287815-2A84A218-FC2F-4E77-804D-DB9CEE0BEC33Q38297145-2C1B1B59-22E0-4ED1-BEB5-D92E5BEB5585Q38807251-F67699BD-DE76-4F3E-8D14-CBF2A6CBC1C3Q38840796-E4B3BA58-5B7A-4335-8333-DE639D8B2BB7Q39281589-0F5D1A9A-8989-4562-84C0-54FDCEA8F83CQ42095529-EB517F2F-E436-4BAE-A84B-EEE2B3E1C634Q42724602-D9CE66F8-4562-43B0-BB11-EDEDAF66F10FQ47995007-91F756BE-9483-40D2-BEBA-521E12502D7BQ55511704-BEC4F07E-1612-42A8-ABA5-33C24341DE29Q56481410-9AB11BF3-4115-4A9C-9386-FA825D482CA7Q58856029-3CBBE43C-7965-4E77-B79A-05FDBB437414
P2860
HTS and hit finding in academia--from chemical genomics to drug discovery.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
HTS and hit finding in academia--from chemical genomics to drug discovery.
@ast
HTS and hit finding in academia--from chemical genomics to drug discovery.
@en
type
label
HTS and hit finding in academia--from chemical genomics to drug discovery.
@ast
HTS and hit finding in academia--from chemical genomics to drug discovery.
@en
prefLabel
HTS and hit finding in academia--from chemical genomics to drug discovery.
@ast
HTS and hit finding in academia--from chemical genomics to drug discovery.
@en
P2860
P1433
P1476
HTS and hit finding in academia--from chemical genomics to drug discovery.
@en
P2093
Iain T Collie
Julie A Frearson
P2860
P304
P356
10.1016/J.DRUDIS.2009.09.004
P577
2009-09-28T00:00:00Z
2009-12-01T00:00:00Z